Skip to main content
Fig. 5 | Genes & Nutrition

Fig. 5

From: Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk

Fig. 5

Differential expression of mRNA (Log2 fold difference from placebo) grouped according to biological pathway. A Adipose tissue inflammation. B Systemic inflammation, and C chronic disease. The prebiotic + probiotic supplement (PreticX® Xylooligosaccharide; 0.8 g/day; AIDP; City of Industry, CA, USA; MegaDuo® Bacillus subtilis HU58 and Bacillus coagulans SC-208; 3 billion CFU/day; Microbiome Labs, LLC; Phoenix, AZ, USA) was compared to a placebo (rice flour) group. A random, double-blind approach was used to assign participants to each condition. The dotted horizontal line represents no change relative to placebo at a given timepoint. Values above the dotted horizontal line are an increase in differential expression relative to placebo, and values below the dotted horizontal line represent a decrease in differential expression relative to placebo. The size of each spot is proportional to the Log2 change in differential mRNA expression from placebo

Back to article page

Genes & Nutrition

ISSN: 1865-3499

Contact us